Sohn Catherine A.

SEC Form 4 insider trading activity

Sohn Catherine A. has filed 2 SEC Form 4 filings (7 transaction rows) across 2 companies, including MAZE, ALT, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jan 8, 2026.

On the most recent filing, Sohn Catherine A. is listed as Director at Maze Therapeutics, Inc. Inside the rolling window, Sohn Catherine A. reported 1 open-market purchase totaling $2K in ALT and 2 open-market sales totaling $1.1M in MAZE. The largest disclosed transaction in the window is a sale of 26,920 MAZE shares on Jan 7, 2026, worth $1.1M.

Companies traded

Other insiders at MAZE

Insider Buying

$2K

reported purchases (SEC code P)

Insider Selling

$1.1M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
MAZESale$96KJan 8SEC ↗
MAZESale$1.1MJan 8SEC ↗
ALTPurchase$2KJan 5SEC ↗
Showing 1–3 of 3
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Sohn Catherine A. made?

Sohn Catherine A. has filed 2 SEC Form 4 filings (7 transaction rows) across 2 companies, including MAZE, ALT since 2026.

Which companies does Sohn Catherine A. trade?

Sohn Catherine A. has filed SEC Form 4 disclosures for 2 companies, including MAZE, ALT.

When was Sohn Catherine A.'s most recent SEC Form 4 filing?

Sohn Catherine A.'s most recent SEC Form 4 filing on Tracefour is dated Jan 8, 2026.

What is Sohn Catherine A.'s total buy and sell value in the current window?

Inside the rolling retention window, Sohn Catherine A. bought $2K and sold $1.1M based on SEC Form 4 filings.

What was Sohn Catherine A.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 26,920 MAZE shares on 2026-01-07, worth $1.1M, per SEC Form 4 filings.